A handheld device which can remotely diagnose the presence of cancer cells is on the horizon with biotech company Universal Biosensors (ASX: UBI) partnering with the Peter MacCallum Cancer Centre on the project. Under the agreement, Peter Mac will supply cancer patient samples to Universal Biosensors which will use the plasma samples in their trials
Read MoreThe content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.